Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
This recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses
Growth team leads financing round in Cleveland Diagnostics; company to advance novel blood-based diagnostic technology to improve and lower costs for patients with cancer
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
Subscribe To Our Newsletter & Stay Updated